Journal of Pathology
期刊全称 | Journal of Pathology | |||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
期刊缩写 | J. Pathol. | |||||||||||||||||||||||||||||||||||||||||||||
涉及主题 (科研通AI识别) | 医学生物遗传学内科学病理化学生物化学免疫学基因内分泌学 | |||||||||||||||||||||||||||||||||||||||||||||
期刊介绍 | The Journal of Pathology aims to serve as a translational bridge between basic biomedical science and clinical medicine with particular emphasis on, but not restricted to, tissue based studies. The main interests of the Journal lie in publishing studies that further our understanding the pathophysiological and pathogenetic mechanisms of human disease. The Journal welcomes investigative studies on human tissues, in vitro and in vivo experimental studies, and investigations based on animal models with a clear relevance to human disease, including transgenic systems. In general, hypothesis driven studies that appropriately employ multiple investigative techniques are preferred over those that rely on a single methodology. As well as original research papers, the Journal seeks to provide rapid publication in a variety of other formats, including editorials, review articles, commentaries and perspectives and other features, both contributed and solicited. Purely descriptive papers on diagnostic pathology (including case reports and prognostic papers without mechanistic and experimental insights) are not considered central to the Journal’s purpose. Correspondence relating to papers published in the Journal will be considered, but only if of general interest. Such correspondance may be published in online versions only, at the Editor's discretion. In determining content, the primary considerations are excellence, relevance and novelty. As the journal of The Pathological Society, it seeks to reflect the broad scientific interests of the Society’s membership but its ethos, authorship, content and purpose are those expected of a leading publication in the international scientific literature. | |||||||||||||||||||||||||||||||||||||||||||||
期刊ISSN | print: 0022-3417 | |||||||||||||||||||||||||||||||||||||||||||||
历年影响因子 |
| |||||||||||||||||||||||||||||||||||||||||||||
历年发表/被引量 (科研通AI通过大数据分析) |
| |||||||||||||||||||||||||||||||||||||||||||||
h-Index | 168 | |||||||||||||||||||||||||||||||||||||||||||||
自引率 | 1.80% | |||||||||||||||||||||||||||||||||||||||||||||
涉及的研究领域 | 医学-病理学 | |||||||||||||||||||||||||||||||||||||||||||||
中科院2025年分区 ? |
| |||||||||||||||||||||||||||||||||||||||||||||
WOS期刊分区 | JCR学科分类
JCI学科分类
| |||||||||||||||||||||||||||||||||||||||||||||
期刊主页 | http://onlinelibrary.wiley.com/journal/10.1002/(ISSN)1096-9896http://www3.interscience.wiley.com/journal/1130/home/ProductInformation.html | |||||||||||||||||||||||||||||||||||||||||||||
投稿网址 | http://mc.manuscriptcentral.com/jpath | |||||||||||||||||||||||||||||||||||||||||||||
出版商 | John Wiley and Sons Ltd | |||||||||||||||||||||||||||||||||||||||||||||
出版国家(地区) | ENGLAND | |||||||||||||||||||||||||||||||||||||||||||||
出版语言 | English | |||||||||||||||||||||||||||||||||||||||||||||
出版周期 | Monthly | |||||||||||||||||||||||||||||||||||||||||||||
每年出版文章数 | 123 | |||||||||||||||||||||||||||||||||||||||||||||
Gold OA文章占比 | 45.53% | |||||||||||||||||||||||||||||||||||||||||||||
原创研究文献占比 (排除综述) | 85.12% | |||||||||||||||||||||||||||||||||||||||||||||
SCI收录类型 | Science Citation Index Expanded (SCIE) Scopus (CiteScore) | |||||||||||||||||||||||||||||||||||||||||||||
PubMed链接 | http://www.ncbi.nlm.nih.gov/nlmcatalog?term=0022-3417%5BISSN%5D | |||||||||||||||||||||||||||||||||||||||||||||
平均审稿周期 | 一般,3-8周 | |||||||||||||||||||||||||||||||||||||||||||||
平均录用比例 | 较难 | |||||||||||||||||||||||||||||||||||||||||||||
相关链接 | 您可以在上述网站查看该期刊的网友互动,及期刊影响力的其它指标。 |